CD163 and esophageal squamous cell carcinoma: To examine the contribution of CAFs to immunoreaction, MØ markers, i.e. CD68 (pan-MØs) and CD163 (M2 MØs) [17], were detected by IHC in the same cohorts of ESCC samples.